Herbal Medication (Gongjin-dan) for Chronic Dizziness — GOODNESS  

Dizziness Chronic Clinical Trial

Official title: Safety, Effectiveness, and Cost-effectiveness of an Herbal Medicine, Gongjin-dan, in Subjects With Chronic Dizziness: a Prospective, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

This is a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group, clinical trial to explore the effectiveness of an herbal medication, Gongjin-dan (GJD) for chronic dizziness (Ménière disease, psychogenic dizziness, or dizziness of unknown cause), identified as liver-deficiency pattern/syndrome, and assessed with Dizziness Handicap Inventory (DHI) ≥ 24 at baseline. Participants will be randomized and allocated to either GJD or placebo group with 1:1 ratio and orally administered GJD or placebo pills once a day for 8 weeks. For collecting data for cost-effectiveness analysis, the participants will be followed up to 12 months from randomization.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Dizziness
• Dizziness Chronic
• Vertigo

• NCT number: NCT03219515
• Study type: Interventional
• Source: Kyunghee University
• Contact: Euiju Lee, Ph.D.
• Phone: +8229589230
• Email: sasangin@daum.net
• Status: Not yet recruiting
• Phase: N/A
• Start date: April 1, 2018
• Completion date: August 30, 2020